SCHEMBL17847909

SCHEMBL17847909

C=CCCc1ccc(-c2ccc(OC)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.59
ALDH1A1 P00352 1/20 0.58
TP53 P04637 1/20 0.58
CYP3A4 P08684 1/20 0.58
ALOX15 P16050 1/20 0.58
TSHR P16473 1/20 0.58
ALOX12 P18054 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
TAAR1 Q96RJ0 1/20 0.50
CALM1 P0DP23 2/20 0.46
AOC3 Q16853 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
IDO1 P14902 1/20 0.44
ESR2 Q92731 1/20 0.44
F2RL1 P55085 1/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905134 0.94 ALDH1A1 (0.64) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL13224766 0.87 ALDH1A1 (0.49) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL3172976 0.87 TP53 (0.49) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL8854472 0.84 HRH3 (0.41) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL8062950 0.83 ALOX15 (0.60) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL7793237 0.82 ALDH1A1 (0.50) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL7793231 0.82 ALDH1A1 (0.50) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL24197395 0.81 MAOB (0.59) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL6056697 0.81 ALOX15 (0.58) MAOBALDH1A1TP53CYP3A4ALOX15
SCHEMBL11228368 0.81 ALDH1A1 (0.88) MAOBALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107109221-B Bimesogenic compounds and mesogenic media 默克专利股份有限公司 2021-03-12 CN disclosed
EP-3257839-B1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2019-09-04 EP disclosed
US-10392561-B2 Bimesogenic compounds and mesogenic media MERCK PATENT GMBH (DE) 2019-08-27 US disclosed
US-10392561-B2 Bimesogenic compounds and mesogenic media MERCK PATENT GMBH (DE) 2019-08-27 US disclosed
EP-3173457-B1 LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY ELEMENT OBTAINED USING SAME DAINIPPON INK & CHEMICALS (JP) 2019-06-05 EP disclosed
EP-3234065-B1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2018-09-26 EP disclosed
US-20170327741-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2017-11-16 US disclosed
US-20170327741-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2017-11-16 US disclosed
US-20170327741-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2017-11-16 US disclosed
EP-3234065-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA Merck Patent GmbH (DE) 2017-10-25 EP disclosed
US-20170218271-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME DIC CORPORATION (JP) 2017-08-03 US disclosed
EP-3173457-A1 LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY ELEMENT OBTAINED USING SAME DIC Corporation (JP) 2017-05-31 EP disclosed
WO-2016096112-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2016-06-23 WO disclosed
WO-2016096112-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327741-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA SP1, FOXM1, S100A11 MAOB 3274/4885ALDH1A1 4654/4885TP53 1989/4885
US-10392561-B2 Bimesogenic compounds and mesogenic media SP1, FOXM1, S100A11 MAOB 3274/4885ALDH1A1 4654/4885TP53 1989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.